Mural Oncology plc
MURA
$2.60
-$0.04-1.52%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
4/23/2025
-
Ticker Report
4/22/2025
-
GuruFocus
4/22/2025
-
TipRanks Financial Blog
4/16/2025
-
MarketBeat
4/16/2025
-
Zacks Investment Research
4/16/2025
-
TipRanks Financial Blog
Five things to know, including Hao's exit, Harvard has allies, pig kidneys and Duolingo for dolphins
4/16/2025
-
Bizjournals.com - Travel news
4/16/2025
-
GuruFocus
4/16/2025
-
Stocktwits News Feed
4/15/2025
-
Benzinga
4/15/2025
-
Bizjournals.com - Health Care News
4/15/2025
-
GuruFocus
4/15/2025
-
GuruFocus
4/15/2025
-
The Fly
4/15/2025
-
The Fly
4/15/2025
-
GuruFocus
4/15/2025
-
Globe Newswire
4/15/2025
-
FierceBiotech.com - Biotech
3/29/2025
-
Ticker Report
3/28/2025
-
SeekingAlpha
3/26/2025
-
MarketBeat
3/26/2025
-
The Fly
3/25/2025
-
The Fly
3/25/2025
-
TipRanks Financial Blog
3/25/2025
-
The Fly
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, March 11, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 12 and 16 (est)
Price History
Beta
--
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
353 1 905 8020
Address
10 Earlsfort Terrace
Dublin, D02 T380
Dublin, D02 T380
Country
Year Founded
Business Description
Sector
--
Industry
--
Mural Oncology plc operates as a clinical-stage oncology company that focuses on discovering and developing immunotherapies for the treatment of patients with cancer. The company’s lead product...
more